Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress
Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress
艾吉納斯宣佈延長BOT/BAL治療在結腸癌中產生明顯的腫瘤縮小；來自調查者贊助的試驗結果發表在2024年ESMO胃腸癌大會上。
Agenus Announces Extended BOT/BAL Therapy Yields Pronounced Tumor Reductions In Colon Cancer; Results From Investigator-Sponsored Trial Presented At 2024 ESMO Gastrointestinal Cancers Congress
艾吉納斯宣佈延長BOT/BAL治療在結腸癌中產生明顯的腫瘤縮小；來自調查者贊助的試驗結果發表在2024年ESMO胃腸癌大會上。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。